Literature DB >> 15950873

A window of opportunity: timing protein degradation by trimming of sugars and ubiquitins.

Gerardo Z Lederkremer1, Michael H Glickman.   

Abstract

Of the many post-translational modifications of proteins, ubiquitination and N-glycosylation stand out because they are polymeric additions. In contrast to single-unit modifications, the fate of the modified protein is determined by the dynamic equilibrium of polymerization versus depolymerization, rather than by the initial addition itself. Notably, it is the trimming of sugar chains and elongation of polyubiquitin that target the protein to degradation. Recent research suggests that, for each process, special receptors recognize chains that reach an appropriate length and commit the conjugated substrate for proteasomal disposal. We propose that the 'magic numbers' are loss of at least three mannose residues from the initial chain, or extension to at least four ubiquitins. Although these processes are compartmentalized to either side of the endoplasmic reticulum (ER) membrane, some proteins are sequentially subjected to both because they transverse this membrane for ER-associated degradation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950873     DOI: 10.1016/j.tibs.2005.04.010

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  43 in total

1.  Inhibition of endoplasmic reticulum-associated degradation rescues native folding in loss of function protein misfolding diseases.

Authors:  Fan Wang; Wensi Song; Giovanna Brancati; Laura Segatori
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

Review 2.  The evolving role of ubiquitin modification in endoplasmic reticulum-associated degradation.

Authors:  G Michael Preston; Jeffrey L Brodsky
Journal:  Biochem J       Date:  2017-02-15       Impact factor: 3.857

3.  A shared endoplasmic reticulum-associated degradation pathway involving the EDEM1 protein for glycosylated and nonglycosylated proteins.

Authors:  Marina Shenkman; Bella Groisman; Efrat Ron; Edward Avezov; Linda M Hendershot; Gerardo Z Lederkremer
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

4.  Evolutionarily conserved glycan signal to degrade aberrant brassinosteroid receptors in Arabidopsis.

Authors:  Zhi Hong; Hiroyuki Kajiura; Wei Su; Hua Jin; Akihisa Kimura; Kazuhito Fujiyama; Jianming Li
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

Review 5.  N-linked glycan recognition and processing: the molecular basis of endoplasmic reticulum quality control.

Authors:  Kelley W Moremen; Maurizio Molinari
Journal:  Curr Opin Struct Biol       Date:  2006-08-30       Impact factor: 6.809

Review 6.  Unfolded Protein Response as a Therapeutic Target in Cardiovascular Disease.

Authors:  Guangyu Zhang; Xiaoding Wang; Thomas G Gillette; Yingfeng Deng; Zhao V Wang
Journal:  Curr Top Med Chem       Date:  2019       Impact factor: 3.295

7.  Mutations of an alpha1,6 mannosyltransferase inhibit endoplasmic reticulum-associated degradation of defective brassinosteroid receptors in Arabidopsis.

Authors:  Zhi Hong; Hua Jin; Anne-Catherine Fitchette; Yang Xia; Andrew M Monk; Loïc Faye; Jianming Li
Journal:  Plant Cell       Date:  2009-12-18       Impact factor: 11.277

8.  Diversity in tissue expression, substrate binding, and SCF complex formation for a lectin family of ubiquitin ligases.

Authors:  Kevin A Glenn; Rick F Nelson; Hsiang M Wen; Adam J Mallinger; Henry L Paulson
Journal:  J Biol Chem       Date:  2008-01-18       Impact factor: 5.157

Review 9.  ER chaperones in mammalian development and human diseases.

Authors:  Min Ni; Amy S Lee
Journal:  FEBS Lett       Date:  2007-04-25       Impact factor: 4.124

10.  Endoplasmic reticulum (ER) mannosidase I is compartmentalized and required for N-glycan trimming to Man5-6GlcNAc2 in glycoprotein ER-associated degradation.

Authors:  Edward Avezov; Zehavit Frenkel; Marcelo Ehrlich; Annette Herscovics; Gerardo Z Lederkremer
Journal:  Mol Biol Cell       Date:  2007-11-14       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.